Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-000160
Filing Date
2024-02-20
Accepted
2024-02-20 17:55:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2787
  Complete submission text file 0001972362-24-000160.txt   4355
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39082 | Film No.: 24655353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RELMADA THERAPEUTICS, INC. 2222 PONCE DE LEON BLVD, 3RD FLOOR CORAL GABLES FL 33134
Business Address
O'Gorman Cedric (Reporting) CIK: 0001962179 (see all company filings)

Type: 144